Abstract
One of the bone's morphogenic protein (BMP) antagonists, Gremlin-1 or GREM-1, can bind directly to BMPs. GREM-1 can act in either BMP-dependent or - independent pathways, according to research. It reinforces organogenesis, tissue differentiation, and organ fibrosis. Recent research from numerous studies has demonstrated the significance of GREM-1 in the initiation, progression, and even metastasis of different cancers, including breast, cervical, gastric, and colorectal cancers. This review highlights the function of GREM-1 in the development of breast cancer and its effect on the cellular procedures and signalling pathways involved in carcinogenesis.
| Original language | English (US) |
|---|---|
| Pages (from-to) | S155-S159 |
| Journal | Journal of the Pakistan Medical Association |
| Volume | 73 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - Feb 2023 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Bone Morphogenetic
- Carcinogenesis
- Colorectal Neoplasms
- Organogenesis
- breast cancers
- stem cells
Fingerprint
Dive into the research topics of 'Recent Advancements in Gremlin-1: Breast cancer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver